Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01405
|
|||||
Drug Name |
Phosphatidylserine
|
|||||
Synonyms |
distearoylphosphatidylserine; LifeExtension PS Caps
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Familial dysautonomia [ICD11: 8C21] | Phase 2 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C42H78NO10P
|
|||||
Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCCCCCC
|
|||||
InChI |
InChI=1S/C42H78NO10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(44)50-35-38(36-51-54(48,49)52-37-39(43)42(46)47)53-41(45)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,38-39H,3-16,21-37,43H2,1-2H3,(H,46,47)(H,48,49)/b19-17-,20-18-/t38-,39+/m1/s1
|
|||||
InChIKey |
WTBFLCSPLLEDEM-JIDRGYQWSA-N
|
|||||
CAS Number |
CAS 70614-14-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 788 | Topological Polar Surface Area | 172 | ||
Heavy Atom Count | 54 | Rotatable Bond Count | 42 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 11 | |||
XLogP |
10.2
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
CHEBI:60568
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT02276716) The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia | |||||
2 | ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010 Apr 24;86(17-18):631-7. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.